382 The synthetic long peptide cancer vaccine UV1 in combination with ipilimumab induces a CD4+ Th1 anti-hTERT immune response and an inflammatory tumor microenvironment in patients with melanoma

Espen B. Ellingsen, Gustav Gaudernack, Sara M. Mangsbo et al.|Regular and Young Investigator Award Abstracts|2021

Cited by 0